Evidence map›Paper›PMID 20371345›Full record

ReviewCell2010

Matrix metalloproteinases: regulators of the tumor microenvironment.

Kai Kessenbrock, Vicki Plaks, Zena Werb

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06967662 (Pilot Study of the Effectiveness of Selective Plasma Adsorption of Extracellular DNA as a Method for Preventing Intraoperative Metastasis in Pancreatic Cancer), which is not on this map. Cited by 2,586 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,586citing papers in PubMed, 5 pooled it
99.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06967662 naenrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Pilot Study of the Effectiveness of Selective Plasma Adsorption of Extracellular DNA as a Method for Preventing Intraoperative Metastasis in Pancreatic Cancer

TypeinterventionalSponsorIlyinskaya Hospital, JSCRan2025 to 2027Enrolled28ConditionsPancreatic Ductal Adenocarcinoma (PDAC)ArmsSelective plasma adsorption of extracellular DNA
3 · Its place in the literature

Who cites it

2,586 citing papers in PubMed, 5 syntheses or guidelines pooled it, 4,974 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Cell plasticity in cancer and therapy resistance.Experimental & molecular medicine · 2026
    Review
  14. Review
  15. Article
  16. De novo design of protease-activatable cytokine prodrugs.bioRxiv : the preprint server for biology · 2026
    Article
  17. Understanding and targeting the tumour matrisome.Nature reviews. Clinical oncology · 2026
    Review
  18. Article
  19. Review
  20. Article

2,526 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kai KessenbrockDepartment of Anatomy and Biomedical Sciences Program, University of California, San Francisco, CA 94143-0452, USA.
Vicki Plaks
Zena Werb
University of California, San Francisco · US

Funding

PROTEASES--TUMOR BIOLOGYP01CA072006 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WERB, ZENA · 1997 to 2007
$10.8M
Role of Metalloproteinases in Mammary Gland RemodelingR01CA057621 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WERB, ZENA · 1993 to 2017
$9.0M
NCI NIH HHS CA057621NCI NIH HHS CA072006NCI NIH HHS P01 CA072006NCI NIH HHS R01 CA057621
6 · The paper itself

Abstract

Extracellular proteolysis mediates tissue homeostasis. In cancer, altered proteolysis leads to unregulated tumor growth, tissue remodeling, inflammation, tissue invasion, and metastasis. The matrix metalloproteinases (MMPs) represent the most prominent family of proteinases associated with tumorigenesis. Recent technological developments have markedly advanced our understanding of MMPs as modulators of the tumor microenvironment. In addition to their role in extracellular matrix turnover and cancer cell migration, MMPs regulate signaling pathways that control cell growth, inflammation, or angiogenesis and may even work in a nonproteolytic manner. These aspects of MMP function are reorienting our approaches to cancer therapy.

Indexed as

AnimalsHumansMatrix Metalloproteinase InhibitorsMatrix MetalloproteinasesNeoplasmsMatrix Metalloproteinase InhibitorsMatrix Metalloproteinases

Identifiers

PMID20371345
PMCPMC2862057
OpenAlexW2005334224

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.